Global Alzheimer’s Disease Drug Market Survey and Trend Research 2018
Summary
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
- Raw Materials
- Cost
- Technology
- Consumer Preference
- History
- Development & Trend
- Market Competition
- Trade Overview
- Policy
- Regional Market
- Production Development
- Sales
- Regional Trade
- Regional Forecast
- Company Profile
- Product & Service
- Business Operation Data
- Market Share
- Market Features
- Investment Opportunity
- Investment Calculation
1 PART 1 INDUSTRY OVERVIEW
1.1 Alzheimer’s Disease Drug Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
1 PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
1 PART 3 ALZHEIMER’S DISEASE DRUG MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Lundbeck. (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Merz Pharma (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Eisai (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Daiichi Sankyo (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Novartis (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Novartis (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Allergan (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Pfizer (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
1 PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
1 PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
1 PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
1 PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
1 PART 9 CONCLUSION
1.1 Alzheimer’s Disease Drug Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
1 PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
1 PART 3 ALZHEIMER’S DISEASE DRUG MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Lundbeck. (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Merz Pharma (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Eisai (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Daiichi Sankyo (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Novartis (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Novartis (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Allergan (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Pfizer (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
1 PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
1 PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
1 PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
1 PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
1 PART 9 CONCLUSION
LIST OF TABLES
Table Global Alzheimer’s Disease Drug Market 2012-2017, by Type, in USD Million
Table Global Alzheimer’s Disease Drug Market 2012-2017, by Type, in Volume
Table Global Alzheimer’s Disease Drug Market Forecast 2018-2023, by Type, in USD Million
Table Global Alzheimer’s Disease Drug Market Forecast 2018-2023, by Type, in Volume
Table Lundbeck. Overview List
Table Alzheimer’s Disease Drug Business Operation of Lundbeck. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merz Pharma Overview List
Table Alzheimer’s Disease Drug Business Operation of Merz Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eisai Overview List
Table Alzheimer’s Disease Drug Business Operation of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Alzheimer’s Disease Drug Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Alzheimer’s Disease Drug Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Alzheimer’s Disease Drug Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Overview List
Table Alzheimer’s Disease Drug Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Alzheimer’s Disease Drug Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Alzheimer’s Disease Drug Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Alzheimer’s Disease Drug Sales Revenue Share, by Companies, in USD Million
Table Global Alzheimer’s Disease Drug Sales Volume 2012-2017, by Companies, in Volume
Table Global Alzheimer’s Disease Drug Sales Revenue Share, by Companies in 2017, in Volume
Table Alzheimer’s Disease Drug Demand 2012-2017, by Application, in USD Million
Table Alzheimer’s Disease Drug Demand 2012-2017, by Application, in Volume
Table Alzheimer’s Disease Drug Demand Forecast 2018-2023, by Application, in USD Million
Table Alzheimer’s Disease Drug Demand Forecast 2018-2023, by Application, in Volume
Table Global Alzheimer’s Disease Drug Market 2012-2017, by Region, in USD Million
Table Global Alzheimer’s Disease Drug Market 2012-2017, by Region, in Volume
Table Alzheimer’s Disease Drug Market Forecast 2018-2023, by Region, in USD Million
Table Alzheimer’s Disease Drug Market Forecast 2018-2023, by Region, in Volume
Table Global Alzheimer’s Disease Drug Market 2012-2017, by Type, in USD Million
Table Global Alzheimer’s Disease Drug Market 2012-2017, by Type, in Volume
Table Global Alzheimer’s Disease Drug Market Forecast 2018-2023, by Type, in USD Million
Table Global Alzheimer’s Disease Drug Market Forecast 2018-2023, by Type, in Volume
Table Lundbeck. Overview List
Table Alzheimer’s Disease Drug Business Operation of Lundbeck. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merz Pharma Overview List
Table Alzheimer’s Disease Drug Business Operation of Merz Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eisai Overview List
Table Alzheimer’s Disease Drug Business Operation of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Alzheimer’s Disease Drug Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Alzheimer’s Disease Drug Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Alzheimer’s Disease Drug Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Overview List
Table Alzheimer’s Disease Drug Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Alzheimer’s Disease Drug Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Alzheimer’s Disease Drug Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Alzheimer’s Disease Drug Sales Revenue Share, by Companies, in USD Million
Table Global Alzheimer’s Disease Drug Sales Volume 2012-2017, by Companies, in Volume
Table Global Alzheimer’s Disease Drug Sales Revenue Share, by Companies in 2017, in Volume
Table Alzheimer’s Disease Drug Demand 2012-2017, by Application, in USD Million
Table Alzheimer’s Disease Drug Demand 2012-2017, by Application, in Volume
Table Alzheimer’s Disease Drug Demand Forecast 2018-2023, by Application, in USD Million
Table Alzheimer’s Disease Drug Demand Forecast 2018-2023, by Application, in Volume
Table Global Alzheimer’s Disease Drug Market 2012-2017, by Region, in USD Million
Table Global Alzheimer’s Disease Drug Market 2012-2017, by Region, in Volume
Table Alzheimer’s Disease Drug Market Forecast 2018-2023, by Region, in USD Million
Table Alzheimer’s Disease Drug Market Forecast 2018-2023, by Region, in Volume
LIST OF FIGURES
Figure Alzheimer’s Disease Drug Industry Chain Structure
Figure Global Alzheimer’s Disease Drug Market Growth 2012-2017, by Type, in USD Million
Figure Global Alzheimer’s Disease Drug Market Growth 2012-2017, by Type, in Volume
Figure Global Alzheimer’s Disease Drug Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Alzheimer’s Disease Drug Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
Figure Alzheimer’s Disease Drug Industry Chain Structure
Figure Global Alzheimer’s Disease Drug Market Growth 2012-2017, by Type, in USD Million
Figure Global Alzheimer’s Disease Drug Market Growth 2012-2017, by Type, in Volume
Figure Global Alzheimer’s Disease Drug Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Alzheimer’s Disease Drug Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
